Availability of assays for definitive diagnosis of primary hyperoxaluria types 1 and 2.


References 1. Shaw LM, Bowers L, Demers L, Freeman D, Moyer T, Sanghvi A, et al. Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring. Clin Chem 1987;33:1269–88. 2. Oellerich M, Armstrong VW, Kahan B, Shaw L, Holt DW, Yatscoff R, et al. Lake Louise Consensus Conference on cyclosporine monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 1995;17:642–54. 3. Armijo JA, Navarro FA, Angeles de Cos M. Is the monoclonal fluorescence polarization immunoassay for cyclosporine specific? Comparison with specific radioimmunoassay. Ther Drug Monit 1992;14:333–8. 4. Beresini MH, Davalian D, Alexander S, TotonQuinn R, Barnett B, Cerelli MJ, et al. Evaluation of EMIT cyclosporine assay for use with whole blood. Clin Chem 1993;39:2235–41. 5. Dusci LJ, Hackett LP, Chiswell GM, Ilet KF. Comparison of cyclosporine measurement in whole blood by HPLC, MFPI and EMIT. Ther Drug Monit 1991;14:327–32. 6. LeGatt DF, Chooi M, Simpson AI, Yatscoff RW. EMIT cyclosporine assay: development of an application protocol for Technicon AXON System. Clin Biochem 1994;27:387–94. 7. Dias VC, LeGatt DF, Yatscoff RW. The EMIT cyclosporine assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers. Clin Biochem 1997; 30:155–62. 8. Seydoux C, Goy JJ. A specific monoclonal antibody for cyclosporine measurement: the clinician’s point of view. Therapie 1997;52:321–5. Renata Fatio* Gabor Sütsch Patrick Pei Ferenc Follath Wolfgang Kiowski Depts. of Intern. Med. and 1 Clin. Chem. University Hosp. Zürich CH 8091, Zürich Switzerland

2 Figures and Tables

Cite this paper

@article{Rumsby1998AvailabilityOA, title={Availability of assays for definitive diagnosis of primary hyperoxaluria types 1 and 2.}, author={Gill Rumsby and Colin Samuell}, journal={Clinical chemistry}, year={1998}, volume={44 3}, pages={694} }